2007

Imaging and prodrug-activating derivatives of chTNT-3 (tumor necrosis therapy) monoclonal antibody

Visit USCO

Text Registration

Imaging and prodrug-activating derivatives of chTNT-3 (tumor necrosis therapy) monoclonal antibody

Status

Published

on 14 Jun 2007

Year of Creation

2000

Barbara Helena Biela

Registration Number

TX0005527798

on 14 Jun 2007

The U.S. Copyright record (Registration Number: TX0005527798) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Imaging and prodrug-activating derivatives of chTNT-3 (tumor necrosis therapy) monoclonal antibody" created in 2000. The copyright holder is Barbara Helena Biela, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Barbara Helena Biela.

Barbara Helena Biela

Application Details

Registration Number

TX0005527798

Registration Date

6/14/2007

Year of Creation

2000

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Computer text data

Personal Authors

Barbara Helena Biela

Notes

Rights Note: Rights and permissions info. on CORDS appl. in CO

Bibliographic Note: Electronic registration

Statements

Author Statement: entire text: Barbara Helena Biela

Notes

Rights Note: Rights and permissions info. on CORDS appl. in CO

Bibliographic Note: Electronic registration

Statements

Author Statement: entire text: Barbara Helena Biela

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.